Mucopolysaccharidosis IVA (Morquio A syndrome): Clinical, biological and therapeutic aspects;La mucopolysaccharidose IVA (syndrome de Morquio A): Aspects clinique, biologique et thérapeutique

Annales de Biologie Clinique

Volumn 65, Issue 1, 2007, Pages 5-11

  Bouzidi, H ^a,b   Khedhiri, S ^b   Laradi, S ^b   Ferchichi, S ^b   Daudon, M ^a   Miled, A ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

Keratan sulfate; Mucopolysaccharidosis IVA; N acetylgalactosamine 6 sulfate sufatase; Systemic bone dysplasia

Indexed keywords

IVA;

GALNS PROTEIN, HUMAN; GLYCOSAMINOGLYCAN; KERATAN SULFATE; N ACETYLGALACTOSAMINE 4 SULFATASE; UNCLASSIFIED DRUG;

BLOOD; FEMALE; GENETICS; HUMAN; MORQUIO SYNDROME; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; REVIEW; URINE;

CHONDROITINSULFATASES; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; KERATAN SULFATE; MUCOPOLYSACCHARIDOSIS IV; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 34147179437     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: 10.1684/abc.2007.0020     Document Type: Review

References (29)

1. Neufeld EF, Muenzer J. The mucoploysaccharidosis. In : Scriver CR, Beaudet AL, Sly WS, Valle D, Kinzler KE, Vogelstein B, eds. The metabolic and molecular bases of inherited diseases. New York : McCraw-Hill, 1995 : 3421-52.
2. Tomatsu S, Montano AM, Nishioka T, et al. Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A). Hum Mutat 2005 ; 26 : 500-12.
3. Ebara S, Kinoshita T, Yuzawa Y, et al. A case of mucopolysaccharidosis IV with lower leg paresis due to thoraco-lumbar kyphoscoliosis. J Clin Neurosci 2003 ; 10 : 358-61.
4. Rolling I, Clausen N, Nyvad B, Sindet-Pederson S. Dental finding in three siblings with Morquio's syndrome. Inter J Paed Dent 1999 ; 9 : 219-24.
5. Tomatsu S, Okamura K, Taketani T, et al. Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA. Pediatr Res 2004 ; 55 : 592-7.
6. Tomatsu S, Fukuda S, Yamagishi A, et al. Mucopolysaccharidosis IVA : four news exonic mutations in patients with N-acetylgalactosamine-6-sulfate sulfatase deficiency. Am J Hum Genet 1996 ; 58 : 950-62.
7. Montano AM, Kaitila I, Sukegawa K, et al. Mucopolysaccharidosis IVA : characterization of a commun mutation found in Finnish patients with attenuated phenotype. Hum Genet 2003 ; 113 : 162-9.
8. Wang L, Ou X, Sebesta I, et al. Combined adenine phosphoribosyl-transferase and N-acetylgalactosamine-6-sulfate sulfatase deficiency. Mol Genet Metab 1999 ; 68 : 78-85.
9. Tomatsu S, Fukuda S, Massue M, et al. Morquio disease : isolation, characterization and expression of full-length cDNA for human N-acetylgalactosamine-6-sulfate sulfatase. Biochem Biophys Res Commun 1991 ; 181 : 677-82.
10. Hori T, Tomatsu S, Nakashima Y, et al. Mucopolysaccharidosis type IVA : common double deletion in the N-acetylgalactosamine-6-sulfatase gene (GALNS). Genomics 1995 ; 26 : 535-42.
11. Tomatsu S, Dieter T, Schwartz IV, et al. Identification of common mutation in mucopolysaccharidosis IVA : correlation among genotype, phenotype, and keratan sulfate. J Hum Genet 2004 ; 49 : 490-4.
12. Laradi S, Tukel T, Khedhiri S, et al. Mucopolysaccharidosis type IV : N-acetylgalactosamine-6-sulfatase mutations in Tunisian patients. Mol Genet Metab 2006 ; 87 : 213-8.
13. Fukuda S, Tomatsu S, Cooper A, et al. Mucopolysaccharidosis IV A (Morquio A) : three novel small deletion in the N-acetylgalactosamine-6-sulfate sulfatase gene. Hum Mutat 1996 ; 8 : 187-90.
14. Sukegawa K, Nakamura H, Kato Z, et al. Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes. Hum Mol Genet 2000 ; 9 : 1283-90.
15. Byers S, Rozaklis T, Brumfield LK, Ranieri E, Hopwood JJ. Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses : characterization and basis of a diagnostic test for MPS. Mol Genet Metab 1998; 65: 282-90.
16. Gallegos-Arreola MP, Machorro-Lazo MV, Flores-Martinez SE, et al. Urinary glycosaminoglycan excretion in healthy subjects and in patients with mucopolysaccharidoses. Arch Med Res 2000 ; 31 : 505-10.
17. Panin G, Naia S, Dall'Amico R, et al. Simple spectrophotometric quantification of urinary excretion of glycosaminoglycan sulfates. Clin Chem 1986 ; 32 : 2073-6.
18. De Jong JG, Wevers RA, Laarakkers C, Poorthuis BJ. Dimethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine : a rapid screening procedure for mucopolysaccharidoses. Clin Chem 1989 ; 35 : 1472-7.
19. Mabe P, Valiente A, Soto V, Cornejo VC, Raimann E. Evaluation of reliability for urine mucopolysaccharidosis screening by dimethylene blue and Berry spot tests. Clin Chim Acta 2004 ; 345 : 135-40.
20. Whitley CB, Spielmann RC, Herro G, Teragawa SS. Urinary glycosaminoglycan excretion quantified by an automated semi-micromethod in specimens conveniently transported from around the globe. Mol Genet Metab 2002 ; 75 : 56-64.
21. Tomatsu S, Okamura K, Maeda H, et al. Keratan sulphate levels in mucopolysaccharidoses and mucopolipidoses. J Inherit Metab Dis 2005 ; 28 : 187-202.
22. Van Diggelen OP, Zhao H, Kleijer WJ, et al. A fluormetric enzyme assays for the diagnostic of Morquio disease type A (MPS IVA). Clin Chim Acta 1990 ; 187 : 131-9.
23. Ogawa T, Tomatsu S, Fukuda S, et al. Mucopolysaccharidosis IVA : screening and identification of mutations of the N-acetylgalactosamine-6-sulfate sulfatase gene. Hum Mol Genet 1995 ; 4 : 341-9.
24. Maire I. Actualités diagnostiques et thérapeutiques des mucopolysaccharidoses. Micro Hyg Ali 1993 ; 12 : 20-6.
25. Desnick RJ. Enzyme remplacement and enhancement therapies for lysosomal diseases. J Inherit Metab Dis 2004 ; 27 : 385-410.
26. Souillet G. Indications et résultats des transplantations de cellule souches hématopoiétiques dans les maladies de surcharge lysosomale. Maghreb Médical 1999 (Suppl.) : 22-6.
27. Poenaru L. Thérapie génique des maladies lysosmales. Med Sci (Paris) 1996 ; 12 : 35-46.
28. Eto Y, Shen JS, Meng XL, Ohashi T. Treatment of lysosomal storage disorders : cell therapy and gene therapy. J Inherit Metab Dis 2004 ; 27 : 411-5.
29. Toietta G, Severini GM, Taversari C, et al. Various cells retrovirally transduced with n-acetylgalactosamine-6-sulfate sulfatase correct Morquio skin fibroblasts in vitro. Hum Gene Ther 2001 ; 12 : 2007-16.